neoral cyclosporine 25 mg
INDICATIONS AND USAGE Kidney, Liver, and Heart Transplantation Neoral is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. Neoral has been used in combination with azathioprine and corticosteroids. Rheumatoid Arthritis Neoral is indicated for the treatment of patients with severe active, rheumatoid arthritis where the disease has not adequately responded to methotrexate. Neoral can be used in combination with methotrexate in rheumatoid arthritis patients who do not respond adequately to methotrexate alone. Psoriasis Neoral is indicated for the treatment of adult, nonimmunocompromised patients with severe (i.e., extensive and/or disabling), recalcitrant, plaque psoriasis who have failed to respond to at least one systemic therapy (e.g., PUVA, retinoids, or methotrexate) or in patients for whom other systemic therapies are contraindicated or cannot be tolerated. While rebound rarely occurs, most patients will experience relapse with Neoral as with other therapies upon cessation of treatment.
novartis pharmaceuticals corporation
OVAL GREY Neoral 25 mg
Related Pills
neoral cyclosporine 100 mg
novartis pharmaceuticals corporation
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Neoral ® Soft Gelatin capsules (
CYCLOSPORINE capsules, USP) MODIFIED 25 mg oval, blue-gray imprinted in red, “Neoral” over “25 mg.” Packages of 30 unit-dose blisters (NDC 0078-0246-15). 100 mg oblong, blue-gray imprinted in red, “NEORAL” over “100 mg.” Packages of 30 unit-dose blisters (NDC 0078-0248-15). Store and Dispense In the original unit-dose container at controlled room temperature 68°F to 77°F (20°C to 25°C). Neoral ® Oral Solution (
CYCLOSPORINE oral solution, USP) MODIFIED A clear, yellow liquid supplied in 50 mL bottles containing 100 mg/mL (NDC 0078-0274-22). Store and Dispense In the original container at controlled room temperature 68°F to 77°F (20° to 25°C). Do not store in the refrigerator. Once opened, the contents must be used within two months. At temperatures below 68°F (20°C) the solution may gel; light flocculation or the formation of a light sediment may also occur. There is no impact on product performance or dosing using the syringe provided. Allow to warm to room temperature 77°F (25°C) to reverse these changes. Neoral ® Soft Gelatin capsules (
CYCLOSPORINE capsules, USP) MODIFIED Neoral ® Oral Solution (
CYCLOSPORINE oral solution, USP) MODIFIED Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936 © Novartis Revised: September 2023 T2023-70
More pills like OVAL Neoral 25 mg